197 related articles for article (PubMed ID: 22610285)
21. Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae.
Pai H; Seo MR; Choi TY
Antimicrob Agents Chemother; 2007 Jan; 51(1):366-8. PubMed ID: 17074790
[TBL] [Abstract][Full Text] [Related]
22. An Increase in the clinical isolation of acquired AmpC β-lactamase-producing Klebsiella pneumoniae in Korea from 2007 to 2010.
Park MJ; Kim TK; Song W; Kim JS; Kim HS; Lee J
Ann Lab Med; 2013 Sep; 33(5):353-5. PubMed ID: 24003426
[TBL] [Abstract][Full Text] [Related]
23. Impact of CLSI and EUCAST Cefepime breakpoint changes on the susceptibility reporting for Enterobacteriaceae.
Bork JT; Heil EL; Leekha S; Fowler RC; Hanson ND; Majumdar A; Johnson JK
Diagn Microbiol Infect Dis; 2017 Dec; 89(4):328-333. PubMed ID: 29031525
[TBL] [Abstract][Full Text] [Related]
24. Increased expression levels of chromosomal AmpC β-lactamase in clinical Escherichia coli isolates and their effect on susceptibility to extended-spectrum cephalosporins.
Paltansing S; Kraakman M; van Boxtel R; Kors I; Wessels E; Goessens W; Tommassen J; Bernards A
Microb Drug Resist; 2015 Feb; 21(1):7-16. PubMed ID: 25188329
[TBL] [Abstract][Full Text] [Related]
25. Survival in the environment is a possible key factor for the expansion of Escherichia coli strains producing extended-spectrum β-lactamases.
Starlander G; Yin H; Edquist P; Melhus Å
APMIS; 2014 Jan; 122(1):59-67. PubMed ID: 23755901
[TBL] [Abstract][Full Text] [Related]
26. The molecular characteristics of cefepime-susceptible Escherichia coli and Klebsiella spp. isolates with a positive β-lactamase screening test result but negative confirmation.
Hu F; Wu W; Ye X; Xu X; Zhu D
Eur J Clin Microbiol Infect Dis; 2010 Oct; 29(10):1297-9. PubMed ID: 20549530
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of the Phoenix automated microbiology system for detecting extended-spectrum beta-lactamase in Escherichia coli, Klebsiella species and Proteus mirabilis].
Lee KK; Kim ST; Hong KS; Huh HJ; Chae SL
Korean J Lab Med; 2008 Jun; 28(3):185-90. PubMed ID: 18594169
[TBL] [Abstract][Full Text] [Related]
28. Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients.
Zerr DM; Miles-Jay A; Kronman MP; Zhou C; Adler AL; Haaland W; Weissman SJ; Elward A; Newland JG; Zaoutis T; Qin X
Antimicrob Agents Chemother; 2016 Jul; 60(7):4237-43. PubMed ID: 27139486
[TBL] [Abstract][Full Text] [Related]
29. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases].
Rzeczkowska M; Piekarska K; Gierczyński R
Med Dosw Mikrobiol; 2012; 64(4):285-95. PubMed ID: 23484420
[TBL] [Abstract][Full Text] [Related]
30. Genotypes and cephalosporin susceptibility in extended-spectrum beta-lactamase producing enterobacteriaceae in the community.
Maina D; Revathi G; Kariuki S; Ozwara H
J Infect Dev Ctries; 2012 Jun; 6(6):470-7. PubMed ID: 22706188
[TBL] [Abstract][Full Text] [Related]
31. Molecular β-lactamase characterization of Gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: Efficacies analysed against susceptible and resistant subsets.
Mendes RE; Castanheira M; Woosley LN; Stone GG; Bradford PA; Flamm RK
Int J Antimicrob Agents; 2018 Aug; 52(2):287-292. PubMed ID: 29654893
[TBL] [Abstract][Full Text] [Related]
32. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
Duttaroy B; Mehta S
Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a double synergy differential test (DSDT) for differential detection of ESBL and AmpC-type β-lactamases in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
Sabia C; Gargiulo R; Sarti M
New Microbiol; 2012 Apr; 35(2):221-5. PubMed ID: 22707136
[TBL] [Abstract][Full Text] [Related]
34. [CMY-2-type plasmid-mediated AmpC ß-lactamases emerging in Tucumán, Argentina].
Jure MA; Presti C; Cudmani NM; Grellet LM; López C; Musa EH; Aulet OC; Nieto C; Saavedra L; de Castillo MC
Rev Argent Microbiol; 2011; 43(1):24-7. PubMed ID: 21491062
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of a modified double-disc synergy test for detection of extended spectrum beta-lactamases in AMPC beta-lactamase-producing proteus mirabilis.
Khan MK; Thukral SS; Gaind R
Indian J Med Microbiol; 2008; 26(1):58-61. PubMed ID: 18227600
[TBL] [Abstract][Full Text] [Related]
36. Community spread of extended-spectrum β-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis: a long-term study in Japan.
Chong Y; Shimoda S; Yakushiji H; Ito Y; Miyamoto T; Kamimura T; Shimono N; Akashi K
J Med Microbiol; 2013 Jul; 62(Pt 7):1038-1043. PubMed ID: 23538565
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
Liu HC; Hung YP; Lin HJ; Liu HC; Lee JC; Wu YH; Li CW; Li MC; Ko WC
J Microbiol Immunol Infect; 2016 Aug; 49(4):584-90. PubMed ID: 26692184
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic and molecular characterization of extended-spectrum β-lactamases and AmpC β-lactamases in Klebsiella pneumoniae.
Al-Agamy MH
Pak J Pharm Sci; 2013 Mar; 26(2):291-8. PubMed ID: 23455199
[TBL] [Abstract][Full Text] [Related]
39. Confronting Ceftolozane-Tazobactam Susceptibility in Multidrug-Resistant Enterobacterales Isolates and Whole-Genome Sequencing Results (STEP Study).
Hernández-García M; García-Fernández S; García-Castillo M; Melo-Cristino J; Pinto MF; Gonçalves E; Alves V; Costa E; Ramalheira E; Sancho L; Diogo J; Ferreira R; Silva T; Chaves C; Pássaro L; Paixão L; Romano J; Cantón R;
Int J Antimicrob Agents; 2021 Feb; 57(2):106259. PubMed ID: 33310115
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic and genotypic characterization of extended-spectrum b-lactamases producing Escherichia coli and Klebsiella pneumoniaein a tertiary care hospital in Riyadh, Saudi Arabia.
Somily AM; Arshad MZ; Garaween GA; Senok AC
Ann Saudi Med; 2015; 35(6):435-9. PubMed ID: 26657226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
